作为与年龄相关的黄斑退化症潜在生物标志物的DNA甲基转移酶表达 (DNMT1,DNMT3a和DNMT3b)
Pedro Camacho1, Edna Ribeiro1, Bruno Pereira1,2,3
1H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990096 Lisbon, Portugal.
Journal of clinical medicine
|January 25, 2025
概括
DNA甲基转移酶 (DNMT) 基因表达因年龄相关的黄斑变性 (AMD) 阶段而异. 晚期AMD中DNMT1的下调表明疾病进展和个性化治疗的潜在生物标志物.
科学领域:
- 表观遗传学和分子生物学
- 眼科和视觉科学 眼科和视觉科学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是全球视力丧失的主要原因.
- 目前对AMD的治疗选择有限,这凸显了对新生物标志物的需求.
- 基因甲基转移酶 (DNMTs) 是关键的表观遗传调节剂,在AMD病变发生过程中具有潜在的作用.
研究的目的:
- 在患有与年龄相关的黄斑变性 (AMD) 患者中表达血DNA甲基转移酶 (DNMT1,DNMT3A,DNMT3B) 的特征.
- 调查DNMT在AMD各个阶段的不同表达模式.
- 探索DNMT作为AMD进展的生物标志物的潜力.
主要方法:
- 预期招募38名AMD患者,按疾病严重程度分类 (早期,中期,非排泄性晚期和缩性晚期AMD).
- 综合眼科评估包括视敏度, fundus摄影和OCT.
- 对外围血液样本进行定量实时PCR (qRT-PCR) 分析,以测量DNMT1,DNMT3A和DNMT3B基因表达.
主要成果:
- 与早期/中期AMD相比,在晚期AMD中观察到DNMT1表达的显著下调.
- 在晚期AMD中,缩性AMD (aAMD) 与非排泄性AMD (nAMD) 相比,显示出明显的DNMT1下调.
- DNMT3A和DNMT3B表现出与AMD疾病阶段相关的类似不同的表达模式.
结论:
- 该研究确定了在AMD患者中DNMT基因表达的特定阶段的转录差异.
- 这些发现凸显了DNMT作为监测AMD进展的生物标志物的潜力.
- 对于开发针对AMD的个性化治疗策略,DNMTs可能是有希望的目标.
相关概念视频
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...